Search
for
Sort by
Research 241–270 of 762
- Expression of AKT1 along with AKT2 in granulosa-lutein cells of hyperandrogenic PCOS patients
- Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome
- No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours
- Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities
- Congenital adrenal hyperplasia
- Association between Insulin Resistance and Cardiovascular Risk Factors in Polycystic Ovary Syndrome Patients
- The Effect of Alfacalcidiol and Metformin on Phenotype Manifestations in Women with Polycystic Ovary Syndrome – a Preliminary Study
- An ovarian Leydig cell tumor of ultrasound negative in a postmenopausal woman with hirsutism and hyperandrogenism
- Bone Mineral Density is Unaltered in Women with Polycystic Ovary Syndrome
- Prevalence and Clinical Predictors of Insulin Resistance in Reproductive-Aged Thai Women with Polycystic Ovary Syndrome
- Oligomenorrhoea in Exercising Women
- Hyperandrogenism in Adolescent Girls
- Serum 3α-androstanediol-glucuronide is decreased in nonhirsute women with acne vulgaris
- Finasteride in the Treatment of Hirsutism
- Hirsutism
- Total testosterone to dihydrotestosterone ratio assessed by LC-MS/MS predicts a worse metabolic profile not only in PCOS patients
- Polycystic ovary syndrome: a dermatologic approach
- Novel Systematics of Nomenclature and Classification of Female Functional Androgenization (Including Polycystic Ovary Syndrome and Non-Classic Congenital Adrenal Hyperplasia)
- Clinical manifestations of polycystic ovary syndrome
- Effect of metformin by employing 2-hour postload insulin for measuring insulin resistance in Taiwanese women with polycystic ovary syndrome
- Polycystic Ovary Syndrome (PCOS): From Diagnosis to Treatment
- Ethinylestradiol/Chlormadinone Acetate for Use in Dermatological Disorders
- PCOS and Obesity: Contraception Challenges
- Study of Cutaneous Manifestations of Polycystic Ovarian Syndrome
- Clinical use of 5α-reductase inhibitors
- Urinary 5-ene-steroid excretion in non-classical congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency (NC-3BHSD)
- Polyzystisches Ovar-Syndrom (PCOS)
- Physiological perspective of Hirsutism in Unani Medicine: An Overview and Update
- Nonclassic congenital adrenal hyperplasia and the heterozygote carrier
- Synergistic Potential of Ecklonia cava and Oral Contraceptives inManaging Polycystic Ovary Syndrome: Clinical and BiochemicalEvaluation